
March 13 (Reuters) - Dogwood Therapeutics Inc DWTX.O:
DOGWOOD THERAPEUTICS, INC. ANNOUNCES PRICING OF $4.8 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES
DOGWOOD THERAPEUTICS INC: PROCEEDS FROM FINANCING, WHEN ADDED TO EXISTING CASH, FUND OPERATIONS THROUGH Q1 2026